Fautrel B, Sibilia J, Mariette X, Combe B (2004) Tumor necrosis factor (alpha) blocking agents in refractory adult Still’s disease: an observational study of 20 cases. Ann Rheum Dis 64:262–266
Google Scholar
Husni ME, Maier AL, Mease PJ, Overman SS, Fraser P, Gravallese EM, Weinblatt ME (2002) Etanercept in the treatment of adult patients with Still’s disease. Arthritis Rheum 46:1171–1176
Google Scholar
Magadur-Joly G, Billaud E, Barrier JH, Pennec YL, Masson C, Renou P, Prost A (1995) Epidemiology of adult Still’s disease: estimate of the incidence by a retrospective study in west France. Ann Rheum Dis 54:587–590
Google Scholar
Cush JJ, Medsger TA Jr, Christy WC, Herbert DC, Cooperstein LA (1987) Adult-onset Still’s disease. Clinical course and outcome. Arthritis Rheum 30:186–194
Google Scholar
Uppal SS, Pande IR, Kumar A, Kailash S, Sekharan NG, Adya CM, Malaviya AN (1995) Adult-onset Still’s disease in northern India: comparison with juvenile onset Still’s disease. Br J Rheumatol 34:429–434
Google Scholar
Caramaschi P, Biasi D, Carletto A, Bambara LM (2002) A case of adult-onset Still’s disease treated with infliximab. Clin Exp Rheumatol 20:113
Google Scholar
Cavagna L, Caporali R, Epis O, Bobbio-Pallavicini F, Montecucco C (2001) Infliximab in the treatment of adult Still’s disease refractory to conventional therapy. Clin Exp Rheumatol 19:329–332
Google Scholar
Kokkinos A, Iliopoulos A, Greka P, Efthymiou A, Katsilambros N, Sfikakis PP (2004) Successful treatment of refractory adult-onset Still’s disease with infliximab. A prospective, non-comparative series of four patients. Clin Rheumatol 23:45–49
Google Scholar
Kraetsch HG, Antoni C, Kalden JR, Manger B (2001) Successful treatment of a small cohort of patients with adult-onset of Still’s disease with infliximab: first experiences. Ann Rheum Dis 60 [Suppl 3]:iii55–iii57
Google Scholar
Olivieri I, de Stefano G, Padula A, La Gala A, de Stefano C (2003) Infliximab in a case of early adult-onset Still’s disease. Clin Rheumatol 22:369–370
Google Scholar
Asherson RA, Pascoe L (2002) Adult-onset Still’s disease: response to Enbrel. Ann Rheum Dis 61:859–860
Google Scholar
Fleischmann R, Iqbal I, Nandeshwar P, Quiceno A (2002) Safety and efficacy of disease-modifying anti-rheumatic agents: focus on the benefits and risks of etanercept. Drug Saf 25:173–197
Google Scholar
Dechant C, Schauenberg P, Antoni CE, Kraetsch HG, Kalden JR, Manger B (2004) Longterm outcome of TNF blockade in adult-onset Still’s disease. Dtsch Med Wochenschr 129:1308–1312
Google Scholar
Yamaguchi M, Ohta A, Tsunematsu T, Kasukawa R, Mizushima Y, Kashiwagi H, Kashiwazaki S, Tanimoto K, Matsumoto Y, Ota T (1992) Preliminary criteria for classification of adult Still’s disease. J Rheumatol 19:424–430
Google Scholar
Hench PK (1989) Evaluation and differential diagnosis of fibromyalgia. Approach to diagnosis and management. Rheum Dis Clin North Am 15:19–29
Google Scholar
Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, Clark P (1990) The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 33:160–172
Google Scholar